T. Rowe Price Associates’s Arcellx ACLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-45,954
Closed -$5.28M – 3240
2026
Q1
$5.28M Sell
45,954
-1,564,847
-97% -$138M ﹤0.01% 1403
2025
Q4
$105M Buy
1,610,801
+346,750
+27% +$27.7M 0.01% 620
2025
Q3
$104M Sell
1,264,051
-174,722
-12% -$12.6M 0.01% 612
2025
Q2
$94.7M Sell
1,438,773
-400,851
-22% -$25M 0.01% 580
2025
Q1
$121M Sell
1,839,624
-281,698
-13% -$19.1M 0.01% 518
2024
Q4
$163M Buy
2,121,322
+220,711
+12% +$19.1M 0.02% 473
2024
Q3
$159M Buy
1,900,611
+269,921
+17% +$18M 0.02% 479
2024
Q2
$90M Buy
1,630,690
+286,137
+21% +$15.6M 0.01% 569
2024
Q1
$93.5M Buy
1,344,553
+84,373
+7% +$5.35M 0.01% 565
2023
Q4
$69.9M Buy
1,260,180
+323,309
+35% +$14.6M 0.01% 612
2023
Q3
$33.6M Sell
936,871
-120,910
-11% -$4.17M ﹤0.01% 787
2023
Q2
$33.4M Buy
1,057,781
+1,035,556
+4,659% +$39.6M ﹤0.01% 816
2023
Q1
$686K Sell
22,225
-71,244
-76% -$2.16M ﹤0.01% 1972
2022
Q4
$2.9M Buy
+93,469
New +$2.14M ﹤0.01% 1338

Other funds holding ACLX

T. Rowe Price Associates's ACLX Position: Q2 2026 in Review

T. Rowe Price Associates sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 45,954 shares — an estimated $5.28M sold.

T. Rowe Price Associates first reported a position in ACLX in Q4 2022 and held it in 14 quarters. The position peaked at $163M in Q4 2024. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • T. Rowe Price Associates reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 45,954 Arcellx shares in Q2 2026, an estimated $5.28M.
  • T. Rowe Price Associates first reported a position in Arcellx in Q4 2022 and held it in 14 quarters.
  • T. Rowe Price Associates's Arcellx position peaked at $163M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.